Literature DB >> 32838261

Pandemic-related pregnancy stress and anxiety among women pregnant during the coronavirus disease 2019 pandemic.

Heidi Preis1, Brittain Mahaffey2, Cassandra Heiselman3, Marci Lobel4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32838261      PMCID: PMC7295479          DOI: 10.1016/j.ajogmf.2020.100155

Source DB:  PubMed          Journal:  Am J Obstet Gynecol MFM        ISSN: 2589-9333


× No keyword cloud information.

Objective

Prenatal maternal stress and anxiety, whether at times of disaster or not, are well-established risk factors for preterm birth, low birthweight, and infant health problems and may have long-lasting effects on the offspring. , Approximately 21% to 25% of women experience prenatal anxiety symptoms (eg, excessive worry, nervousness, agitation). Policies to decrease the spread of the novel coronavirus disease 2019 (COVID-19) by sheltering in place and social distancing and increases in unemployment, poverty, and intimate partner violence have dramatically changed the daily lives of pregnant women and presumably heightened maternal stress and subsequent anxiety. The COVID-19 pandemic has created an urgent need to examine the extent to which pandemic-related stress predicts heightened anxiety in women pregnant during this crisis.

Study Design

At the end of April 2020, 788 pregnant women were recruited through social media to complete an online questionnaire. Study inclusion criteria were being pregnant at the time of questionnaire completion and older than 18 years. Exclusion was inability to read or write English. The study was approved by the Institutional Review Board of Stony Brook University. The questionnaire included sociodemographic factors (maternal age, ethnicity and race, financial status, health insurance, lifetime experience of emotional or physical abuse), current use of psychiatric medications, obstetrical factors (parity, gestational age, pregnancy risk, chronic medical conditions, planned pregnancy, fertility treatments), prenatal behaviors (eg, vitamins, exercise, enough sleep), alterations to prenatal care appointments (cancellation or rescheduling owing to COVID-19), and anxiety (generalized anxiety disorder-7 [GAD-7] with the following clinical cutoff values: 0–4, no to minimal; 5–9, mild; 10–14, moderate; and 15–21, severe). COVID-19-related concerns were assessed using the pandemic-related pregnancy stress (PREPS) scale, a novel instrument developed by our research team. Exploratory factor analysis on a random half of the sample confirmed its 3 constituent factors as follows: preparedness stress (7 items; eg, “I am worried I will not be able to have someone with me during the delivery”), perinatal infection stress (5 items; eg, “I am worried that my baby could get COVID-19 at the hospital after birth”), and positive appraisal (3 items; not relevant to this study). Confirmatory factor analysis on the second half of the sample indicated good model fit as follows: comparative fit index, 0.93; Tucker-Lewis index, 0.92; root mean square error of approximation, 0.076; and standardized root mean square residual, 0.079. Stress scales were internally consistent (Cronbach’s α>0.80). We used hierarchical binary logistic regression to predict odds risk for minimal or mild anxiety vs moderate or severe anxiety.

Results

Participants were on average aged 29.2±5.3 years and their average gestational age was 25.3±9.1 weeks. Approximately three-quarters were white and non-Hispanic (n=608, 77.2%); almost half were primiparas (n=362, 45.9%). A total of 166 women (21.1%) reported no to minimal anxiety symptoms (GAD-7=0–4), 280 (35.6%) reported mild anxiety symptoms (GAD-7=5–9), 170 (21.6%) reported moderate anxiety symptoms (GAD-7=10–14), and 171 (21.7%) reported severe anxiety symptoms (GAD-7≥15). Logistic regression predicted moderate or severe anxiety from all sociodemographic and obstetrical background variables and the 2 PREPS scales (Table ). The first step included sociodemographic variables (R 2=0.07) and the second step included medical and obstetrical variables (ΔR 2=0.09). The last step included all previous variables as confounders and added the 2 PREPS scales (ΔR 2=0.12). In the final model (total R 2=0.28), abuse history, high-risk pregnancy, preparedness stress, and perinatal infection stress all independently predicted greater likelihood of moderate or severe anxiety. Older maternal age and better prenatal health behaviors were protective against anxiety.
Table

Binary multivariate hierarchical logistic regression predicting moderate or severe anxiety symptoms (n=788)

Step 1
Step 2
Step 3
aOR95% CIaOR95% CIaOR95% CI
Older maternal age0.54b0.36–0.810.39c0.24–0.610.46b0.28–0.74
Racial and ethnic minority0.910.64–1.290.970.67–1.411.240.83–1.85
Married or cohabiting0.760.49–1.160.710.45–1.130.750.46–1.22
Financial insecurity1.130.78–1.640.910.61–1.350.860.56–1.30
Abuse history2.06c1.44–2.951.82b1.25–2.661.85b1.24–2.75
Private insurance0.790.55–1.40.780.53–1.160.820.53–1.25
Primipara1.070.77–1.471.250.89–1.77
Gestational age1.000.99–1.021.000.98–1.01
Planned pregnancy1.110.78–1.591.210.83–1.77
Fertility treatment0.830.48–1.450.790.44–1.43
Chronic illness1.290.91–1.841.180.82–1.72
High riskd1.79b1.27–2.531.52a1.06–2.19
Healthy behaviors0.64c0.54–0.750.65c0.54–0.78
Appointment altered1.49a1.09–2.021.120.81–1.56
Psychiatric medication0.860.50–1.460.740.42–1.31
PREPS scale—preparedness1.75c1.35–2.26
PREPS scale—infection1.55c1.28–1.88
R2=0.07R2=0.16R2=0.28

aOR, adjusted odds ratio; CI, confidence interval; PREPS, pandemic-related pregnancy stress.

Preis et al. Pandemic-related pregnancy stress and anxiety. AJOG MFM 2020.

P<.05

P<.01

P<.001

Women who reported being high risk and those who were unsure were grouped together.

Binary multivariate hierarchical logistic regression predicting moderate or severe anxiety symptoms (n=788) aOR, adjusted odds ratio; CI, confidence interval; PREPS, pandemic-related pregnancy stress. Preis et al. Pandemic-related pregnancy stress and anxiety. AJOG MFM 2020. P<.05 P<.01 P<.001 Women who reported being high risk and those who were unsure were grouped together.

Conclusion

Pregnant women during the COVID-19 pandemic experienced substantial anxiety as indicated by the high prevalence of mild, moderate, and severe anxiety in this sample. Stress related to preparation for birth during the pandemic and worries about COVID-19 infection to self and the baby can elevate women’s risk of experiencing moderate or severe anxiety over and above sociodemographic, obstetrical, and other health relevant factors. Brief interventions to improve self-efficacy and motivate women to engage in healthy activities could be useful in decreasing anxiety. Engaging women in-person or through telemedicine and providing information regarding COVID-19 infection safety procedures for labor, delivery, and postpartum would likely alleviate some stress and subsequent anxiety. Women should also be routinely screened for psychosocial vulnerabilities, especially during this pandemic. It is more important than ever to identify and refer women experiencing substantial anxiety and those who have previously experienced emotional or physical abuse because they may be at an increased risk while sheltering in place with an abusive partner. As the COVID-19 public health crisis evolves, additional research is imperative to evaluate mental health difficulties in pregnant and postpartum women and examine the resilience and risk factors associated with favorable outcomes vs persistent psychopathology and their effects on perinatal and long-term health.
  4 in total

Review 1.  Conceptualization, measurement, and effects of pregnancy-specific stress: review of research using the original and revised Prenatal Distress Questionnaire.

Authors:  Sirena M Ibrahim; Marci Lobel
Journal:  J Behav Med       Date:  2019-06-10

2.  The COVID-19 pandemic, psychological stress during pregnancy, and risk of neurodevelopmental disorders in offspring: a neglected consequence.

Authors:  Amir Abdoli; Shahab Falahi; Azra Kenarkoohi; Morteza Shams; Hamed Mir; Mirza Ali Mofazzal Jahromi
Journal:  J Psychosom Obstet Gynaecol       Date:  2020-05-08       Impact factor: 2.949

Review 3.  Disasters and perinatal health:a systematic review.

Authors:  Emily Harville; Xu Xiong; Pierre Buekens
Journal:  Obstet Gynecol Surv       Date:  2010-11       Impact factor: 3.015

4.  Psychological impact of coronavirus disease 2019 in pregnant women.

Authors:  Gabriele Saccone; Alessia Florio; Federica Aiello; Roberta Venturella; Maria Chiara De Angelis; Mariavittoria Locci; Giuseppe Bifulco; Fulvio Zullo; Attilio Di Spiezio Sardo
Journal:  Am J Obstet Gynecol       Date:  2020-05-07       Impact factor: 8.661

  4 in total
  46 in total

1.  "I had so many life-changing decisions I had to make without support": a qualitative analysis of women's pregnant and postpartum experiences during the COVID-19 pandemic.

Authors:  Grayson B Ashby; Kirsten A Riggan; Lily Huang; Vanessa E Torbenson; Margaret E Long; Myra J Wick; Megan A Allyse; Enid Y Rivera-Chiauzzi
Journal:  BMC Pregnancy Childbirth       Date:  2022-07-04       Impact factor: 3.105

2.  The Effect of Music Intervention on Fetal Education via Doppler Fetal Monitor.

Authors:  Liza Lee; Yu-Hsin Chang; Wei-Ju Liang; Yao-Cing Huang
Journal:  Children (Basel)       Date:  2022-06-18

3.  Pregnant at the start of the pandemic: a content analysis of COVID-19-related posts on online pregnancy discussion boards.

Authors:  Rebekah Choi; Ashwini Nagappan; Deena Kopyto; Anna Wexler
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-16       Impact factor: 3.105

4.  Depression, Anxiety, Resilience, and Coping: The Experience of Pregnant and New Mothers During the First Few Months of the COVID-19 Pandemic.

Authors:  Patricia A Kinser; Nancy Jallo; Ananda B Amstadter; Leroy R Thacker; Evelyn Jones; Sara Moyer; Amy Rider; Nicole Karjane; Amy L Salisbury
Journal:  J Womens Health (Larchmt)       Date:  2021-04-12       Impact factor: 2.681

5.  Adverse Perinatal Outcomes Predicted by Prenatal Maternal Stress Among U.S. Women at the COVID-19 Pandemic Onset.

Authors:  Heidi Preis; Brittain Mahaffey; Susmita Pati; Cassandra Heiselman; Marci Lobel
Journal:  Ann Behav Med       Date:  2021-03-20

6.  The use of personal protective equipment as an independent factor for developing depressive and post-traumatic stress symptoms in the postpartum period.

Authors:  Hadar Gluska; Yael Mayer; Noga Shiffman; Rawan Daher; Lior Elyasyan; Nofar Elia; Maya Sharon Weiner; Hadas Miremberg; Michal Kovo; Tal Biron-Shental; Liat Helpman; Rinat Gabbay-Benziv
Journal:  Eur Psychiatry       Date:  2021-05-04       Impact factor: 5.361

7.  Mental health among pregnant women with COVID-19-related stressors and worries in the United States.

Authors:  Jihong Liu; Peiyin Hung; Anthony J Alberg; Nicole L Hair; Kara M Whitaker; Jessica Simon; Sherri K Taylor
Journal:  Birth       Date:  2021-05-19       Impact factor: 3.081

8.  Substance use and mental health in pregnant women during the COVID-19 pandemic.

Authors:  Crystal Lederhos Smith; Sara F Waters; Danielle Spellacy; Ekaterina Burduli; Olivia Brooks; Cara L Carty; Samantha Ranjo; Sterling McPherson; Celestina Barbosa-Leiker
Journal:  J Reprod Infant Psychol       Date:  2021-04-17

9.  Elevated risk for obsessive-compulsive symptoms in women pregnant during the COVID-19 pandemic.

Authors:  Brittain L Mahaffey; Amanda Levinson; Heidi Preis; Marci Lobel
Journal:  Arch Womens Ment Health       Date:  2021-07-16       Impact factor: 4.405

10.  Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID-19 Pandemic in Italy.

Authors:  Chiara Colli; Chiara Penengo; Marco Garzitto; Lorenza Driul; Alessia Sala; Matilde Degano; Heidi Preis; Marci Lobel; Matteo Balestrieri
Journal:  Int J Womens Health       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.